ExL Events will be holding its 3rd Due Diligence Summit for Life Sciences on May 18-19, 2016 in Boston, MA. The conference will offer presentations on the following topics:
• Develop a Road Map for an Efficient and Comprehensive Intellectual Property Due Diligence Investigation
• On-Site Visits -- Shared Learnings to Help Optimize Your Due Diligence
• Understand the Role of Investment Banks and External Advisors in the Due Diligence Process
• Panel: Best Practices for Working with External Partners
• The Biotech Perspective -- How to Make the Case for Your Product for Licensing or Acquisition
• Case Study: Develop an Alliance Management Action Plan
• Case Study: Zimmer Biomet’s Post-Merger Integration of the Dental Group
• Panel: The Different Approaches to Integration Planning
• Best Practices for Identifying and Evaluating Potential Business Development Opportunities
• Panel: Strategic Approaches to Reduce Risks and Ensure Success when Identifying and Assessing a Target
• Critical Operational Aspects of the Out-Licensing Process to Ensure Success
• Explore Risk-Based Methodologies for Medical Device Valuations
• Consolidation, Divestitures and Leveraging Out-Licensing as an Effective Portfolio Management Strategy
• Case Study: Bayer’s In-Licensing Deal with Ionis Pharmaceuticals
• Best Practices for Mid-Sized Companies Preparing to Acquire or In-License a Product
An agenda for the conference can be found here. A complete brochure for this conference, including an agenda, detailed descriptions of conference sessions, and list of speakers can be obtained here.
The registration fee for the conference is $2,095. Those interested in registering for the conference can do so here [http://exlevents.com/3rd-due-diligence-summit-for-life-sciences/pricing/].
Patent Docs is a media partner of the Due Diligence Summit for Life Sciences.
Comments